The Significance of PSA Screening by Primary Care Physicians
Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses the significance of prostate-specific antigen (PSA) screening by primary care physicians.
Werntz explains that, prior to PSA screening, about one-fourth to one-fifth of men presented with metastatic disease as a first complaint. Unfortunately, at this point, the disease may be incurable.
Currently, only about 4% of men are presenting with metastatic disease, and Werntz believes that is due to PSA screening. Werntz also urges physicians to continue to recommend PSA screening so as to not repeat the past.
As for evolution of treatment, Werntz believes it starts with PSA screening and knowing how frequent patients may need it. Werntz mentions that surgical treatment is getting better day by day as well.
Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses the significance of prostate-specific antigen (PSA) screening by primary care physicians.
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
